Session Details
[27-60-am]Science for Drug Formulation 6, DDS/Genetic drug delivery system
Fri. Mar 27, 2026 9:30 AM - 11:30 AM JST
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Room 60 (4101, Bldg. 4, Area 4 [1F]) (1)
Discusser: Keiichi Motoyama, Toshiro Fukami
[27-60-am-01]Characterization of Biodegradable Micelles Containing mRNA in Comparison with LNP Formulations
○mai hazekawa1, daisuke watase1, ayano yamada1, mitsuhisa koga1 (1. Fac. Pharm., Fukuoka Univ)
[27-60-am-02S]Research on Transdermal Formulation of Edaravone: Effects of Different Solvents on Skin Permeability
○Haruka Nii1, Moeka Ikeda1, Sakura Okada1, Daisuke Uesugi2, Satoshi Murao1, Akihiro Matsumoto1 (1. Faculty of Pharmacy,Osaka Ohtani Univ., 2. Shima Trading Company)
[27-60-am-03S]Tabletting of protein powder through compression and humidification process: Achieving both high physical strength and rapid dispersibility in water
○Nene Sugisaka1, Aya Shiramizu1, Takahiro Sato2, Keita Kondo1, Toshiyuki Niwa1 (1. Meijo Univ, 2. Nagase & Co., Ltd.)
[27-60-am-04S]Research on Hemi-Porous Janus Particles: Investigation of Preparation Methods
○Miku Yamamoto1, Satoshi Murao1, Takeo Kitazawa2, Yuta Hatori2, Masayuki Kaneda3, Syou Maki4, Akihiro Matsumoto1 (1. Faculty of Pharmacy,Osaka Ohtani Univ., 2. Faculty of Pharmacy,Yasuda Women's Univ., 3. Faculty of Engineering,Osaka Metropolitan Univ., 4. Faculty of Science,Okayama University of Science)
[27-60-am-05S]Research into transdermal absorption formulation of edaravone: Examination of patch formulation
○RIKO DOI1, Moeka Ikeda1, Sakura Okada1, Daisuke Uesugi2,1, Satoshi Murao1, Akihiro Matsumoto1 (1. Faculty of Pharmacy, 2. Shima Trading Company)
[27-60-am-06S]Formulation Design of PVP-Based Nanoparticles for Improving the Solubility and Pharmaceutical Potential of Morin Hydrate
○Yi Ting Li1, Chun Yin Yang1 (1. Department of Pharmacy and Master Program, College of Pharmacy and Health, Tajen University, Pingtung, Taiwan)
[27-60-am-07S]Preparation and physicochemical characterization of pterostilbene-loaded HPβCD–PVP nanoparticles
○Yin-Chen Hsu1, Chun-Yin Yang1 (1. Dept. Pharm. & Master Prog., Coll. Pharm. & Health, Tajen Univ.)
[27-60-am-08S]Formulation design of olanzapine transdermal sheet −Optimization of electrospinning conditions and enhancement of skin permeability using nanofiber sheet−
○Yusuke Kinoshita1, Yuri Ikeuchi1, Yuduki Kougo1, Ayane Tahira1, Takumi Watanabe1, Yasuko Obata1 (1. Hoshi University)
[27-60-am-09S]Enhancement of glabridin solubility and in vitro permeation by PVA nanofiber sheets
○Kota Takahashi1, Eriko Yamazoe1, Takaaki Ito1, Junpei Horikoshi2, Atsushi Takeoka3, Kohei Tahara1 (1. Gifu Pharmaceutical University, 2. Tribeaute, 3. ZeroGravity)
[27-60-am-10S]Development of drug-containing nanofibers using electrospinning for oral disintegrating formulations
○Honoka Shimura1, Eriko Yamazoe1, Takaaki Ito1, Kohei Tahara1 (1. Gifu Pharmaceutical University)
